Page last updated: 2024-08-25

bexarotene and Carcinoma, Renal Cell

bexarotene has been researched along with Carcinoma, Renal Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chowdhury, P; Davies, P; Dere, R; Karki, M; Mancini, MA; Park, YS; Powell, RT; Stephan, C; Talley, T; Tripathi, DN; Uray, IP	1
Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A	1
Kast, RE	1

Reviews

2 review(s) available for bexarotene and Carcinoma, Renal Cell

Article	Year
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature. American journal of hematology, 2008, Volume: 83, Issue:9 Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Contraindications; Exanthema; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Incidental Findings; Kidney Neoplasms; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Simvastatin; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine	2008
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. Cancer biology & therapy, 2008, Volume: 7, Issue:10 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Hepacivirus; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Models, Biological; Multiple Myeloma; Ribavirin; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin	2008

Article

Year

CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.

American journal of hematology, 2008, Volume: 83, Issue:9

Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Contraindications; Exanthema; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Incidental Findings; Kidney Neoplasms; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Simvastatin; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine

2008

Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.

Cancer biology & therapy, 2008, Volume: 7, Issue:10

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Hepacivirus; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Models, Biological; Multiple Myeloma; Ribavirin; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin

2008

Other Studies

1 other study(ies) available for bexarotene and Carcinoma, Renal Cell

Article	Year
Bexarotene - a novel modulator of AURKA and the primary cilium in Journal of cell science, 2018, 12-14, Volume: 131, Issue:24 Topics: Aurora Kinase A; Bexarotene; Carcinoma, Renal Cell; Cell Line, Tumor; Cilia; Gene Expression Regulation, Neoplastic; Humans; Mutation; Von Hippel-Lindau Tumor Suppressor Protein	2018